7 February 2025
Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Cancer Drug Development


We are delighted to share some highly viewed papers on cancer drug development that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.

The list of relevant papers can be seen below:

“Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs”
by Virginia Metrangolo and Lars H. Engelholm
Cancers 2024, 16(2), 447; https://doi.org/10.3390/cancers16020447
Available online: https://www.mdpi.com/2072-6694/16/2/447

“Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer”
by Xin Gu and Tamara Minko
Cancers 2024, 16(8), 1589; https://doi.org/10.3390/cancers16081589
Available online: https://www.mdpi.com/2072-6694/16/8/1589

“Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989”
by Othman Al Musaimi
Cancers 2024, 16(5), 1032; https://doi.org/10.3390/cancers16051032
Available online: https://www.mdpi.com/2072-6694/16/5/1032

“Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review”
by Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, Mahima Bansode, Kratika Khunteta, Priyanka Vijay Sonar, Ameya Hebale, Vaishnavi Salokhe and Birandra Kumar Sinha
Cancers 2024, 16(4), 680; https://doi.org/10.3390/cancers16040680
Available online: https://www.mdpi.com/2072-6694/16/4/680

“Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma”
by Ali Al Sbihi, Maryam Alasfour and Georgios Pongas
Cancers 2024, 16(4), 827; https://doi.org/10.3390/cancers16040827
Available online: https://www.mdpi.com/2072-6694/16/4/827

“DDX3X and Stress Granules: Emerging Players in Cancer and Drug Resistance”
by Han Zhang, Paula M. Mañán-Mejías, Hannah N. Miles, Andrea A. Putnam, Leonard R. MacGillivray and William A. Ricke
Cancers 2024, 16(6), 1131; https://doi.org/10.3390/cancers16061131
Available online: https://www.mdpi.com/2072-6694/16/6/1131

Special Issues:

Drug Targeting Therapy in Multiple Myeloma
Guest Editors: Dr. Hiroshi Handa and Prof. Dr. Hideto Tamura
Submission deadline: 11 April 2025

Recent Advances in PROteolysis TArgeting Chimeras (PROTACs)
Guest Editors: Prof. Dr. Dhimant Desai and Dr. Mourad Zerfaoui
Submission deadline: 15 March 2025

 

 

Understanding the Complexities of Anticancer Drugs Resistance
Guest Editors: Dr. Mariarosaria Conte and Dr. Nunzio Del Gaudio
Submission deadline: 30 May 2025

Drug Repurposing and Reformulation for Cancer Treatment: 2nd Edition
Guest Editors: Dr. Arati Sharma, Prof. Dr. Dhimant Desai and Dr. Abhijit Date
Submission deadline: 15 June 2025

 

 

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Back to TopTop